Actinium Pharmaceuticals (ATNM) Other Working Capital Changes (2022 - 2026)
Actinium Pharmaceuticals (ATNM) posted quarterly Other Working Capital Changes of -$172000.0 for Q1 2026, down 24.64% year-over-year from -$228230.8 in Q1 2025, and down 11.69% quarter-over-quarter from -$154000.0 in Q4 2025.
Actinium Pharmaceuticals (ATNM) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Actinium Pharmaceuticals (ATNM) has reported Other Working Capital Changes for 5 consecutive years, with -$172000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 24.64% year-over-year to -$172000.0; the TTM figure through Mar 2026 stood at -$611000.0 (down 13.36% YoY), while the FY2025 annual figure was -$577000.0, down 8.87% from the prior year.
- Other Working Capital Changes slipped to -$172000.0 in Q1 2026 per ATNM's latest filing, from -$154000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $2.0 million in Q1 2023 and bottomed at -$1.6 million in Q3 2023.
- Historically, Other Working Capital Changes has averaged -$88529.4 across 5 years, with a median of -$126000.0 in 2025.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes plunged 568.42% — and 2024, when it retreated 6.56%.
- Actinium Pharmaceuticals' Other Working Capital Changes stood at -$19000.0 in 2022, then slumped by 568.42% to -$127000.0 in 2023, then slipped by 7.09% to -$136000.0 in 2024, then declined by 13.24% to -$154000.0 in 2025, then retreated by 11.69% to -$172000.0 in 2026.
- Business Quant data shows ATNM's Other Working Capital Changes at -$172000.0 in Q1 2026, -$154000.0 in Q4 2025, and -$145000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - |
| 10 | Actinium Pharmaceuticals | 34.85 Mn | 34.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -34.83 Mn |
| Jun 30, 2026 | -34.83 Mn |
| Jun 30, 2026 | -34.83 Mn |
| Mar 31, 2026 | -172,000.00 |
| Mar 31, 2026 | -172,000.00 |
| Mar 31, 2026 | -172,000.00 |
| Dec 31, 2025 | -154,000.00 |
| Dec 31, 2025 | -154,000.00 |
| Dec 31, 2025 | -154,000.00 |
| Sep 30, 2025 | -145,000.00 |
| Sep 30, 2025 | -145,000.00 |
| Sep 30, 2025 | -145,000.00 |
| Jun 30, 2025 | -140,000.00 |
| Jun 30, 2025 | -140,000.00 |
| Jun 30, 2025 | -140,000.00 |
| Mar 31, 2025 | -138,000.00 |
| Mar 31, 2025 | -138,000.00 |
| Mar 31, 2025 | -138,000.00 |
| Dec 31, 2024 | -136,000.00 |
| Dec 31, 2024 | -136,000.00 |